Heron Therapeutics HRTX
NASDAQ HRTX
$0.32 +0.01 (+2.98%)
At close: Aug 21, 2026 · 4:00 PM EDT

Heron Therapeutics (HRTX) Shares Outstanding (Diluted) (2021 - 2026)

Heron Therapeutics (HRTX) Shares Outstanding (Diluted) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 255.20 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 106.00 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 64.41 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 398.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 115.80 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 138.28 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 241.70 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 217.35 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 556.90 Mn
10 Heron Therapeutics 59.96 Mn 17.29 Mn 26.09 Mn 190.34 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 190.34 Mn
Mar 31, 2026 189.65 Mn
Dec 31, 2025 166.71 Mn
Sep 30, 2025 170.35 Mn
Jun 30, 2025 154.02 Mn
Mar 31, 2025 196.92 Mn
Dec 31, 2024 152.45 Mn
Sep 30, 2024 152.83 Mn
Jun 30, 2024 152.31 Mn
Mar 31, 2024 151.20 Mn
Dec 31, 2023 138.14 Mn
Sep 30, 2023 144.99 Mn
Jun 30, 2023 119.72 Mn
Mar 31, 2023 119.25 Mn
Dec 31, 2022 108,876.00
Sep 30, 2022 111.74 Mn
Jun 30, 2022 102.41 Mn
Mar 31, 2022 102.12 Mn
Dec 31, 2021 98,471.00
Sep 30, 2021 101.91 Mn